These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36215793)

  • 1. A concept mapping study of service user design of safer supply as an alternative to the illicit drug market.
    Pauly B; McCall J; Cameron F; Stuart H; Hobbs H; Sullivan G; Ranger C; Urbanoski K
    Int J Drug Policy; 2022 Dec; 110():103849. PubMed ID: 36215793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
    Mansoor M; Foreman-Mackey A; Ivsins A; Bardwell G
    Harm Reduct J; 2023 Apr; 20(1):61. PubMed ID: 37118799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Am I gonna get in trouble for acknowledging my will to be safe?": Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis.
    Goodyear T; Mniszak C; Jenkins E; Fast D; Knight R
    Harm Reduct J; 2020 Mar; 17(1):23. PubMed ID: 32228646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulant safe supply: a potential opportunity to respond to the overdose epidemic.
    Fleming T; Barker A; Ivsins A; Vakharia S; McNeil R
    Harm Reduct J; 2020 Jan; 17(1):6. PubMed ID: 31924209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.
    Wallace B; van Roode T; Pagan F; Hore D; Pauly B
    BMC Public Health; 2021 Jun; 21(1):1156. PubMed ID: 34134698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safer opioid supply: qualitative program evaluation.
    Haines M; O'Byrne P
    Harm Reduct J; 2023 Apr; 20(1):53. PubMed ID: 37081500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "It's Helped Me a Lot, Just Like to Stay Alive": a Qualitative Analysis of Outcomes of a Novel Hydromorphone Tablet Distribution Program in Vancouver, Canada.
    Ivsins A; Boyd J; Mayer S; Collins A; Sutherland C; Kerr T; McNeil R
    J Urban Health; 2021 Feb; 98(1):59-69. PubMed ID: 33118145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safer opioid distribution in response to the COVID-19 pandemic.
    Tyndall M
    Int J Drug Policy; 2020 Sep; 83():102880. PubMed ID: 32739148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of overdose prevention sites during a public health emergency in Victoria, Canada.
    Pauly B; Wallace B; Pagan F; Phillips J; Wilson M; Hobbs H; Connolly J
    PLoS One; 2020; 15(5):e0229208. PubMed ID: 32438390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everywhere and for everyone: proportionate universalism as a framework for equitable access to community drug checking.
    Wallace B; van Roode T; Burek P; Hore D; Pauly B
    Harm Reduct J; 2022 Dec; 19(1):143. PubMed ID: 36539747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19.
    Carroll JJ; Mackin S; Schmidt C; McKenzie M; Green TC
    Harm Reduct J; 2022 Feb; 19(1):9. PubMed ID: 35120531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
    Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G
    J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Overdose Crisis and Using Alone: Perspectives of People Who Use Drugs in Rural and Semi-Urban Areas of British Columbia.
    Fernando S; Hawkins J; Kniseley M; Sikora M; Robson J; Snyder D; Battle C; Salmon A
    Subst Use Misuse; 2022; 57(12):1864-1872. PubMed ID: 36096482
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study.
    Lew B; Bodkin C; Lennox R; O'Shea T; Wiwcharuk G; Turner S
    Harm Reduct J; 2022 Mar; 19(1):29. PubMed ID: 35313903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study.
    Otiashvili D; Mgebrishvili T; Beselia A; Vardanashvili I; Dumchev K; Kiriazova T; Kirtadze I
    Harm Reduct J; 2022 Mar; 19(1):25. PubMed ID: 35264181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada.
    Glegg S; McCrae K; Kolla G; Touesnard N; Turnbull J; Brothers TD; Brar R; Sutherland C; Le Foll B; Sereda A; Goyer MÈ; Rai N; Bernstein S; Fairbairn N
    Int J Drug Policy; 2022 Aug; 106():103742. PubMed ID: 35679695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.